Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2005
06/02/2005CA2545935A1 Methods for modulating the th2 immune response to an antigen by adding or removing activated carbonyl groups from the antigen
06/02/2005CA2545806A1 Methods of modulating immunity
06/02/2005CA2515890A1 Novel insertion sites in pox vectors
06/01/2005EP1536234A2 Soluble CTLA4 mutant molecules and uses thereof
06/01/2005EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
06/01/2005EP1535915A1 Furan or thiophene derivative and medicinal use thereof
06/01/2005EP1535907A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
06/01/2005EP1535906A1 Nitrogen-containing compounds
06/01/2005EP1535619A1 Poria extract devoid of secolanostane derivatives comprising lanostane derivatives for immunity enhancement
06/01/2005EP1535614A2 Materials and methods for detection and treatment of immune system dysfunctions
06/01/2005EP1535609A1 Nf-kb activation inhibitors
06/01/2005EP1535512A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARa GENE TRANSFERRED THEREINTO AND USE THEREOF
06/01/2005EP1534847A1 Retroviral vector and stable packaging cell lines
06/01/2005EP1534834A2 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
06/01/2005EP1534819A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
06/01/2005EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof
06/01/2005EP1534748A2 Fusion proteins and methods of producing same
06/01/2005EP1534725A2 Compounds and methods for inhibiting selectin-mediated function
06/01/2005EP1534720A1 Mitochondrially targeted antioxidants
06/01/2005EP1534706A1 Furanthiazole derivatives as heparanase inhibitors
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534677A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1
06/01/2005EP1534674A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use
06/01/2005EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
06/01/2005EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
06/01/2005EP1534389A2 Pyrazolopyrimidines as kinase inhibitors
06/01/2005EP1534333A1 A method of immunomodulation
06/01/2005EP1534332A2 Antibodies and uses thereof
06/01/2005EP1534329A2 Vaccine comprising il-13 and an adjuvant
06/01/2005EP1534326A2 Improved bacterial outer membrane vesicles
06/01/2005EP1534324A2 Tumor specific oligosaccharide epitopes and use thereof
06/01/2005EP1534323A2 Il-14 vaccine for the treatment of asthma and atopic disorders
06/01/2005EP1534315A2 Increasing of the resorption of substances via skin and mucous membranes
06/01/2005EP1534290A2 Novel inhibitors of kinases
06/01/2005EP1534286A1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
06/01/2005EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
06/01/2005EP1534281A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace)
06/01/2005EP1534269A1 Oxime conjugates and methods for their formation and use
06/01/2005EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/01/2005EP1534250A2 Electrospun amorphous pharmaceutical compositions
06/01/2005EP1404362A4 Signal-1/signal-2 bifunctional peptide inhibitors
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
06/01/2005EP1218064B1 COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASEs CONTAINING A COMPOUND WHICH INHIBITS ICAM-LFA-1 INTERACTION AND A COMPOUND WHICH INHIBITS CD40-CD40 LIGAND INTERACTION
06/01/2005EP1178977B1 Ion channel modulating agents
06/01/2005EP1171160B1 Method and means for treating post-polio syndrome
06/01/2005EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
06/01/2005CN1622995A Receptor nucleic acids and polypeptides
06/01/2005CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
06/01/2005CN1622957A IFNAR2 mutants, their production and use
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
06/01/2005CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
06/01/2005CN1622941A Glutaminyl based DPIV inhibitors
06/01/2005CN1622819A An anti-rheumatism medicament and preparation method thereof
06/01/2005CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound
06/01/2005CN1622807A Phenylpyrimidine amines as IgE inhibitors
06/01/2005CN1622754A Novel immune effect compound
06/01/2005CN1621083A Improvement of method for preparing healthy qi strengthening, astragalus root and glossy privet fruit containing medicine
06/01/2005CN1621044A Composition for preventing and treating arthritis, formulation containing said composition, its preparation process and usage
06/01/2005CN1204258C Component of bromelain
06/01/2005CN1204238C Kenrel oil composite extracted from plant kernel and its extraction process and medicinal preparation
06/01/2005CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs.
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
06/01/2005CN1203865C Injection for enhancing immunity and its preparing method
06/01/2005CN1203852C Valdecoxib compositions
06/01/2005CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical
06/01/2005CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
05/2005
05/31/2005US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
05/31/2005US6900338 Scavenger compounds
05/31/2005US6900336 8-aza-11-deoxy prostaglandin analogues
05/31/2005US6900334 Antiallergens; autoimmune diseases
05/31/2005US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst
05/31/2005US6900243 Phenylheteroalkylamine derivatives
05/31/2005US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900211 CCR5 antagonists useful for treating aids
05/31/2005US6900205 Antidiabetic agents
05/31/2005US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900027 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents
05/31/2005US6900024 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells
05/31/2005US6899900 Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
05/31/2005US6899893 Method for treating an allergic or inflammatory disease
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899723 Transcutaneous photodynamic treatment of targeted cells
05/31/2005CA2267157C Cancer immunotherapy using tumor cells combined with mixed lymphocytes
05/26/2005WO2005046704A1 Pharmaceutical product comprising tissue of the male vegetal reproductive system
05/26/2005WO2005046569A2 Pharmaceutical compositions for the treatment of sars
05/26/2005WO2005000843A3 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof
05/26/2005WO2004083392A3 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
05/26/2005WO2002093998A9 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
05/26/2005US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
05/26/2005US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases
05/26/2005US20050113451 7-acetamidinyl derivatives
05/26/2005US20050113423 Modulators of ATP-binding cassette transporters
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens
05/26/2005US20050113383 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 1172